News
The firings included 20 individuals in the FDA's Office of Neurological and Physical Medicine Devices.
The company has received 12 US FDA approvals.
The company offers services like sperm cryopreservation, fertility testing, testosterone treatments, and vasectomies.
The aim of the partnership is to research how AI can help predict cancer progression.
The announcement comes just three months after XRHealth announced it acquired cognitive training VR platform NeuroReality and its assets.
The company will use the funds to expand its team and hasten its product direction as demand for its offering accelerates.
After a clinician prescribes a medication, Connect sends the patient a text message with a link to pharmacies offering the lowest price for the drug.
The company will use the funds to enhance the development of its AI capabilities and for commercial growth.
The expansion comes on the heels of the company's opening of a brick-and-mortar clinic in Plano, Texas, and virtually throughout the state late last year.
Vitalchat also garnered $6 million in a Series A round, and Cerula Care secured $3.7 million in an oversubscribed seed funding round.